Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Immunomodulatory Effect of Dasatinib Plus Blinatumomab Versus Ponatinib Plus Blinatumomab in Newly Diagnosed Ph + Acute Lymphoblastic Leukemia Patients

Michela Ansuinelli, Maria Stefania De Propris, Maria Cristina Puzzolo, Nadia Peragine, Tiziano Quacquarelli, Saveria Capria, Cristina Skert, Valentina Mancini, Simona Sica, Federico Lussana, Erika Borlenghi, Marco Cerrano, Daniele Vallisa, Valeria Cardinali, Sabina Chiaretti, Anna Guarini, Robin Foà

Blood (2024) 144 (Supplement 1): 838.

https://doi.org/10.1182/blood-2024-208827

Published: 2024

Journal Articles

Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study

Blood (2021) 138 (25): 2727–2730.

https://doi.org/10.1182/blood.2021011883

Published: 2021

Includes: Supplemental data

Journal Articles

Host immune system modulation in Ph + acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

Maria Cristina Puzzolo, Giulia Radice, Nadia Peragine, Maria Stefania de Propris, Paola Mariglia, Marco Vignetti, Antonella Vitale, Renato Bassan, Mario Annunziata, Gianluca Gaidano, Alessandro Rambaldi, Sabina Chiaretti, Anna Guarini, Robin Foà

Blood (2021) 138 (22): 2290–2293.

https://doi.org/10.1182/blood.2021011822

Published: 2021

Includes: Supplemental data

Journal Articles

Rapid Identification of BCR/ABL1 -like Acute Lymphoblastic Leukemia (ALL) Cases By Quantitative Real Time-PCR (Q-RT-PCR). Generation and Validation of a Predictive Statistical Model

Sabina Chiaretti, Sara Grammatico, Alfonso Piciocchi, Monica Messina, Anna Lucia Fedullo, Valentina Gianfelici, Grazia Fazio, PhD, Nadia Peragine, Maria Paola Martelli, Paola Fazi, Marco Vignetti, Antonella Vitale, Cyril Salek, Gianni Cazzaniga, PhD, Anna Guarini, Robin Foà

Blood (2015) 126 (23): 1410.

https://doi.org/10.1182/blood.V126.23.1410.1410

Published: 2015

Journal Articles

Expanded Natural Killer Cells For The Control Of Minimal Residual Disease In Ph+ Acute Lymphoblastic Leukemia Patients

Giovanni Fernando Torelli, MD, Nadia Peragine, PhD, Sara Raponi, PhD, Paola Mariglia, BS, Simona Pauselli, MD, Maria Stefania De Propris, PhD, Antonella Vitale, Anna Guarini, Robin Foá, MD

Blood (2013) 122 (21): 2026.

https://doi.org/10.1182/blood.V122.21.2026.2026

Published: 2013

Journal Articles

Single Cell Network Profiling (SCNP) of Early-Stage Chronic Lymphocytic Leukemia (CLL): Association with p53, IGHV Mutational Status and Time to First Treatment (TTFT)

Jason Ptacek, PhD, Erik Evensen, Rachael E. Hawtin, Ph.D., Greg Friedland, Jodi R. Ware, PharmD, James Cordeiro, Nadia Peragine, Ph.D, Alessandra Cesano, M.D., Ph.D., Robin Foà, MD, Anna Guarini, PhD

Blood (2012) 120 (21): 1783.

https://doi.org/10.1182/blood.V120.21.1783.1783

Published: 2012

Journal Articles

Distribution of Genetic and Molecular Prognostic Markers in Young Patients with Chronic Lymphocytic Leukemia (CLL) in Different Phases of the Disease.

Ilaria Del Giudice, Francesca Romana Mauro, Mauro Nanni, Rita Barzotti, Maria Stefania De Propris, Sara Raponi, Simona Santangelo, Marilisa Marinelli, Nadia Peragine, Daniele Armiento, Francesca Paoloni, Anna Guarini, Robin Foà

Blood (2009) 114 (22): 4373.

https://doi.org/10.1182/blood.V114.22.4373.4373

Published: 2009

Journal Articles

Functional Analysis and Gene Expression Profile of Umbilical Cord Blood Regulatory T Cells.

Giovanni Fernando Torelli, Roberta Maggio, Nadia Peragine, Sabina Chiaretti, Maria Stefania De Propris, Maria Screnci, Barbarella Lucarelli, Maria Grazia Mascolo, Anna Paola Iori, Gabriella Girelli, Anna Guarini, Robert Foà

Blood (2009) 114 (22): 4085.

https://doi.org/10.1182/blood.V114.22.4085.4085

Published: 2009

Journal Articles

Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases

Ilaria Del Giudice, Sabina Chiaretti, Simona Tavolaro, Maria Stefania De Propris, Roberta Maggio, Francesca Mancini, Nadia Peragine, Simona Santangelo, Marilisa Marinelli, Francesca Romana Mauro, Anna Guarini, Robin Foà

Blood (2009) 114 (3): 638–646.

https://doi.org/10.1182/blood-2008-12-196568

Published: 2009

Includes: Supplemental data

Journal Articles

A Prospective Study of Young Chronic Lymphocytic Leukemia (CLL) Patients Investigated at Diagnosis: Distribution and Clinical Significance of Prognostic Factors

Ilaria Del Giudice, Francesca Romana Mauro, Maria Stefania De Propris, Simona Santangelo, Marilisa Marinelli, Nadia Peragine, Valeria Di Maio, Mauro Nanni, Francesca Mancini, Daniele Armiento, Luisa Quattrocchi, Francesca Paoloni, Anna Guarini, Robert Foa

Blood (2008) 112 (11): 3121.

https://doi.org/10.1182/blood.V112.11.3121.3121

Published: 2008

Journal Articles

ATM Gene Alterations in CLL Patients Induce Gene Profile Clusters and Predict Disease Progression.

Anna Guarini, Marilisa Marinelli, Simona Tavolaro, Isabella Torrente, Emanuele Bellacchio, Monia Magliozzi, Simona Santangelo, Nadia Peragine, Maria Stefania De Propris, Mauro Nanni, Sabina Chiaretti, Francesca Romana Mauro, Ilaria Del Giudice, Bruno Dallapiccola, Robert Foa

Blood (2008) 112 (11): 2084.

https://doi.org/10.1182/blood.V112.11.2084.2084

Published: 2008

Journal Articles

BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells

Anna Guarini, Sabina Chiaretti, Simona Tavolaro, Roberta Maggio, Nadia Peragine, Franca Citarella, Maria Rosaria Ricciardi, Simona Santangelo, Marilisa Marinelli, Maria Stefania De Propris, Monica Messina, Francesca Romana Mauro, Ilaria Del Giudice, Robert Foà

Blood (2008) 112 (3): 782–792.

https://doi.org/10.1182/blood-2007-12-127688

Published: 2008

Includes: Supplemental data

Journal Articles

T Regulatory Cells Obtained from Cord Blood Are Greatly Expandable and Exert Potent Suppressive Function.

Giovanni F. Torelli, MD, PhD, Roberta Maggio, BS, Nadia Peragine, BS, Barbarella Lucarelli, MD, Maria S. De Propris, PhD, Maria Screnci, MD, Simona Salvatori, BS, Anna P. Iori, MD, PhD, Filippo Milano, MD, Veronica Valle, MD, Emilia Iannella, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2007) 110 (11): 4862.

https://doi.org/10.1182/blood.V110.11.4862.4862

Published: 2007

Journal Articles

Gene Expression Profile Reveals a Unique Pattern of Protein Kinases in Chronic Lymphocytic Leukemia (CLL): Potential Role of the Second Generation Protein Kinase Inhibitors.

Simona Tavolaro, BS, Sabina Chiaretti, MD, PhD, Monica Messina, BS, Nadia Peragine, BS, Roberta Maggio, BS, Ilaria Del Giudice, MD, PhD, Emanuela M. Ghia, PhD, Francesca R. Mauro, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2007) 110 (11): 3117.

https://doi.org/10.1182/blood.V110.11.3117.3117

Published: 2007

Journal Articles

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

Simona Tavolaro, BS, Roberta Maggio, BS, Nadia Peragine, BS, Monica Messina, BS, Franca Citarella, PhD, Simona Santangelo Miss, Marilisa Marinelli, BS, Maria R. Ricciardi, PhD, Maria S. De Propris, PhD, Ilaria Del Giudice, MD, PhD, Francesca R. Mauro, MD, Sabina Chiaretti, MD, PhD, Robert Foa, MD, Anna Guarini, PhD

Blood (2007) 110 (11): 1133.

https://doi.org/10.1182/blood.V110.11.1133.1133

Published: 2007

Journal Articles

Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia

Blood (2007) 109 (11): 4944–4951.

https://doi.org/10.1182/blood-2006-12-062398

Published: 2007

Includes: Supplemental data

Journal Articles

The MicroRNA (miR) Profile in B-Cell Chronic Lymphocytic Leukemia (CLL) Reveals a Differential Expression of miR-21, miR-155 and miR-150 between Leukemic and Normal B Lymphocytes, and of miR-150, miR-29bc and miR-223 between IgV H Mutated and Unmutated Patients.

Sabina Chiaretti, MD, PhD, Valerio Fulci, PhD, Marina Goldoni, BS, Gianluca Azzalin, Mr, Simona Tavolaro, BS, Monica Messina, BS, Roberta Maggio, BS, Nadia Peragine, BS, Simona Santangelo Miss, Francesca R. Mauro, MD, Anna Guarini, PhD, Giuseppe Macino, PhD, Robert Foa, MD

Blood (2006) 108 (11): 298.

https://doi.org/10.1182/blood.V108.11.298.298

Published: 2006

Journal Articles

Angiogenic Activity in IgV H Mutated and Unmutated Chronic Lymphocytic Leukemia (CLL): Indications for the Therapeutic Use of VEGF-Signaling Inhibitors.

Roberta Maggio, BS, Nadia Peragine, BS, Monica Messina, BS, Sabina Chiaretti, MD PhD, Stefania M. De Propris, PhD, Simona Tavolaro, BS, Marilisa Marinelli, BS, Elisabetta Calabrese, BS, Ilaria Del Giudice, MD PhD, Francesca R. Mauro, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 2819.

https://doi.org/10.1182/blood.V108.11.2819.2819

Published: 2006

Journal Articles

Dendritic Cell-Based Immunotherapeutic Strategies in Adult Acute Lymphoid Leukemia Patients Treated with Conventional Therapy or with Imatinib.

Anna Guarini, PhD, Roberta Maggio, BSc, Maria Stefania De Propris, PhD, Nadia Peragine, Monica Messina, Elisabetta Calabrese, MD, Cristina Ariola, BSc, Giovanna Meloni, MD, Antonella Vitale, MD, Robert Foà, MD

Blood (2005) 106 (11): 1835.

https://doi.org/10.1182/blood.V106.11.1835.1835

Published: 2005

NARROW

Immunomodulatory Effect of Dasatinib Plus Blinatumomab Versus Ponatinib Plus Blinatumomab in Newly Diagnosed Ph + Acute Lymphoblastic Leukemia Patients

Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study

Host immune system modulation in Ph + acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

Rapid Identification of BCR/ABL1 -like Acute Lymphoblastic Leukemia (ALL) Cases By Quantitative Real Time-PCR (Q-RT-PCR). Generation and Validation of a Predictive Statistical Model

Expanded Natural Killer Cells For The Control Of Minimal Residual Disease In Ph+ Acute Lymphoblastic Leukemia Patients

Single Cell Network Profiling (SCNP) of Early-Stage Chronic Lymphocytic Leukemia (CLL): Association with p53, IGHV Mutational Status and Time to First Treatment (TTFT)

Distribution of Genetic and Molecular Prognostic Markers in Young Patients with Chronic Lymphocytic Leukemia (CLL) in Different Phases of the Disease.

Functional Analysis and Gene Expression Profile of Umbilical Cord Blood Regulatory T Cells.

Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases

A Prospective Study of Young Chronic Lymphocytic Leukemia (CLL) Patients Investigated at Diagnosis: Distribution and Clinical Significance of Prognostic Factors

ATM Gene Alterations in CLL Patients Induce Gene Profile Clusters and Predict Disease Progression.

BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells

T Regulatory Cells Obtained from Cord Blood Are Greatly Expandable and Exert Potent Suppressive Function.

Gene Expression Profile Reveals a Unique Pattern of Protein Kinases in Chronic Lymphocytic Leukemia (CLL): Potential Role of the Second Generation Protein Kinase Inhibitors.

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia

The MicroRNA (miR) Profile in B-Cell Chronic Lymphocytic Leukemia (CLL) Reveals a Differential Expression of miR-21, miR-155 and miR-150 between Leukemic and Normal B Lymphocytes, and of miR-150, miR-29bc and miR-223 between IgV H Mutated and Unmutated Patients.

Angiogenic Activity in IgV H Mutated and Unmutated Chronic Lymphocytic Leukemia (CLL): Indications for the Therapeutic Use of VEGF-Signaling Inhibitors.

Dendritic Cell-Based Immunotherapeutic Strategies in Adult Acute Lymphoid Leukemia Patients Treated with Conventional Therapy or with Imatinib.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only